Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)

Historical Holders from Q2 2014 to Q1 2025

Symbol
ALDX on Nasdaq
CUSIP
01438T106
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
59.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
37.1M
Holdings value
$185M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
117
Number of buys
58
Number of sells
-37
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 8.2% $33.2M 4.88M Perceptive Advisors LLC Apr 3, 2025

Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 405K $2.33M +$95.2K $5.75 9
2024 Q4 37.1M $185M +$2.53M $4.99 117
2024 Q3 36.4M $196M +$6.36M $5.39 112
2024 Q2 35.3M $117M +$1.5M $3.31 103
2024 Q1 21.9M $71.6M -$640K $3.27 53
2023 Q4 35.1M $123M -$17.4M $3.51 102
2023 Q3 37.8M $252M -$9.93M $6.68 119
2023 Q2 39M $327M +$24.7M $8.39 118
2023 Q1 35.6M $353M +$15.5M $9.93 106
2022 Q4 34.2M $238M -$18.9M $6.96 92
2022 Q3 36.8M $197M +$1.91M $5.34 81
2022 Q2 36.2M $145M -$7.66M $3.99 84
2022 Q1 38.5M $171M +$11.5M $4.45 99
2021 Q4 36.1M $144M -$45.2M $4.00 107
2021 Q3 39.7M $349M -$59.1M $8.78 114
2021 Q2 45.2M $513M +$154M $11.33 129
2021 Q1 31.7M $376M +$119M $11.88 105
2020 Q4 19.9M $136M -$9.94M $6.86 90
2020 Q3 23.8M $176M +$71.1M $7.41 83
2020 Q2 14.6M $61M -$6.62M $4.17 76
2020 Q1 16.8M $41.4M -$6.41M $2.47 69
2019 Q4 17.7M $103M +$1.35M $5.81 74
2019 Q3 15.5M $81.7M +$645K $5.27 66
2019 Q2 16.9M $101M +$1.18M $6.00 73
2019 Q1 16.4M $148M -$5.57M $9.03 76
2018 Q4 17.1M $141M -$14.2M $8.30 73
2018 Q3 18M $247M +$80.3M $13.80 86
2018 Q2 12.1M $96.4M +$14.6M $7.95 65
2018 Q1 10.3M $77.1M +$3.82M $7.50 41
2017 Q4 9.76M $66.4M +$4.22M $6.80 34
2017 Q3 9.21M $65.8M +$12.7M $7.20 34
2017 Q2 7.44M $34.7M -$2.55M $4.65 24
2017 Q1 7.9M $38M +$8.37M $5.00 24
2016 Q4 6.14M $32.8M +$112K $5.35 20
2016 Q3 6.11M $47.9M -$1.31M $7.82 22
2016 Q2 6.36M $36.2M +$11.4M $5.69 24
2016 Q1 4.37M $18.3M -$216K $4.19 25
2015 Q4 4.43M $30M +$376K $6.78 20
2015 Q3 4.33M $25.2M +$601K $5.83 22
2015 Q2 4.21M $32.8M +$19.5M $7.76 22
2015 Q1 1.69M $17.4M +$8.39M $10.18 15
2014 Q4 870K $6.28M +$82K $7.18 5
2014 Q3 859K $5.16M +$34.2K $5.49 5
2014 Q2 852K $5.64M +$5.64M $6.56 5